Method for producing parvovirus having high infectivity titer and high purity
US10808227B2 · kind B2 · utility
0Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2016 |
| Grant date | Oct 20, 2020 |
| Priority date | — |
| Expiry date | Oct 14, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14351
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided are a parvovirus derived from an unconcentrated cell culture supernatant, having a infectivity titer of 109 TCID50/mL or more and an {infectivity titer (TCID50/mL)}:{impurity protein concentration (ng/mL)} ratio more than 5000:1; and a method of producing such a high-infectivity titer and high-purity parvovirus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.